4.5 Article

Both mutated and unmutated memory B cells accumulate mutations in the course of the secondary response and develop a new antibody repertoire optimally adapted to the secondary stimulus

期刊

INTERNATIONAL IMMUNOLOGY
卷 25, 期 12, 页码 683-695

出版社

OXFORD UNIV PRESS
DOI: 10.1093/intimm/dxt030

关键词

Antibody repertoire; memory B cells; secondary response; somatic hypermutation

资金

  1. National Institute of Allergy and Infectious Diseases (NIAID) [AI064752]
  2. Grants-in-Aid for Scientific Research [23380073] Funding Source: KAKEN

向作者/读者索取更多资源

High-affinity memory B cells are preferentially selected during secondary responses and rapidly differentiate into antibody-producing cells. However, it remains unknown whether only high-affinity, mutated memory B cells simply expand to dominate the secondary response or if in fact memory B cells with a diverse V-H repertoire, including those with no mutations, accumulate somatic mutations to create a new repertoire through the process of affinity maturation. In this report, we took a new approach to address this question by analyzing the V-H gene repertoire of IgG1(+) memory B cells before and after antigen re-exposure in a host unable to generate IgG(+) B cells. We show here that both mutated and unmutated IgG1(+) memory B cells respond to secondary challenge and expand while accumulating somatic mutations in their V-H genes in a stepwise manner. Both types of memory cells subsequently established a V-H gene repertoire dominated by two major clonotypes, which are distinct from the original repertoire before antigen re-exposure. In addition, heavily mutated memory B cells were excluded from the secondary repertoire. Thus, both mutated and unmutated IgG1(+) memory cells equally contribute to establish a new antibody repertoire through a dynamic process of mutation and selection, becoming optimally adapted to the recall challenge.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Tissue-resident CD4+ T helper cells assist the development of protective respiratory B and CD8+ T cell memory responses

Young Min Son, In Su Cheon, Yue Wu, Chaofan Li, Zheng Wang, Xiaochen Gao, Yao Chen, Yoshimasa Takahashi, Yang-Xin Fu, Alexander L. Dent, Mark H. Kaplan, Justin J. Taylor, Weiguo Cui, Jie Sun

Summary: The study reveals a population of tissue-resident helper T cells in the lung, termed as T-RH cells, which play a critical role in promoting the development of protective B cell and CD8(+) T cell responses. These T-RH cells are dependent on transcription factors BCL6 and Bhlhe40 and deliver local help to CD8(+) T cells through IL-21-dependent mechanisms.

SCIENCE IMMUNOLOGY (2021)

Article Virology

Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan

Masaru Takeshita, Naoshi Nishina, Saya Moriyama, Yoshimasa Takahashi, Yoshifumi Uwamino, Mika Nagata, Wataru Aoki, Katsunori Masaki, Makoto Ishii, Hideyuki Saya, Yasushi Kondo, Yuko Kaneko, Katsuya Suzuki, Koichi Fukunaga, Tsutomu Takeuchi

Summary: The study found that asymptomatic and mild COVID-19 patients had inadequate humoral immune responses, with most antibodies being correlated with disease severity, symptoms such as pneumonia, lymphopenia, and certain serological markers, and some patients failing to develop antibodies against the virus.

VIROLOGY (2021)

Article Multidisciplinary Sciences

MRC5 cells engineered to express ACE2 serve as a model system for the discovery of antivirals targeting SARS-CoV-2

Kentaro Uemura, Michihito Sasaki, Takao Sanaki, Shinsuke Toba, Yoshimasa Takahashi, Yasuko Orba, William W. Hall, Katsumi Maenaka, Hirofumi Sawa, Akihiko Sato

Summary: The study aimed to develop a virus-susceptible human cell line for SARS-CoV-2 research, with findings showing that MRC5/ACE2 cells will be crucial in the development of specific anti-viral therapeutics and in assisting vaccine development to combat SARS-CoV-2 infections.

SCIENTIFIC REPORTS (2021)

Article Immunology

Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients

Hidetsugu Fujigaki, Masato Inaba, Michiko Osawa, Saya Moriyama, Yoshimasa Takahashi, Tadaki Suzuki, Kenya Yamase, Yukihiro Yoshida, Yo Yagura, Takayoshi Oyamada, Masao Takemura, Yohei Doi, Kuniaki Saito

Summary: This study investigated the kinetics and neutralizing activity of various Ag-specific Ab isotypes against SARS-CoV-2 in serum of COVID-19 patients, with IgG against RBD showing the best correlation with virus-neutralizing activity. The results provide valuable information for the selection of serological tests for seroprevalence and vaccine evaluation studies.

JOURNAL OF IMMUNOLOGY (2021)

Article Microbiology

Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro

Kaho Shionoya, Masako Yamasaki, Shoya Iwanami, Yusuke Ito, Shuetsu Fukushi, Hirofumi Ohashi, Wakana Saso, Tomohiro Tanaka, Shin Aoki, Kouji Kuramochi, Shingo Iwami, Yoshimasa Takahashi, Tadaki Suzuki, Masamichi Muramatsu, Makoto Takeda, Takaji Wakita, Koichi Watashi

Summary: Mefloquine, an anti-malarial drug, demonstrated higher anti-SARS-CoV-2 activity than Hydroxychloroquine, inhibiting viral entry to target cells and showing synergistic antiviral activity when combined with other drugs. Mathematical modeling predicted that standard dosage of Mefloquine could reduce viral load and shorten the time until virus elimination in patients.

FRONTIERS IN MICROBIOLOGY (2021)

Article Immunology

Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized Mice

Ryutaro Iwabuchi, Keigo Ide, Kazutaka Terahara, Ryota Wagatsuma, Rieko Iwaki, Hiroko Matsunaga, Yasuko Tsunetsugu-Yokota, Haruko Takeyama, Yoshimasa Takahashi

Summary: The study reveals that CD14(+)CD1c(+) cells in humanized mouse models are phenotypically distinct from cDC2s, indicating their identity as a subset equivalent to DC3s.

FRONTIERS IN IMMUNOLOGY (2021)

Article Cell Biology

Association of HLA-DRB1*09:01 with severe COVID-19

Alitzel Anzurez, Izumi Naka, Shoji Miki, Kaori Nakayama-Hosoya, Mariko Isshiki, Yusuke Watanabe, Midori Nakamura-Hoshi, Sayuri Seki, Takayuki Matsumura, Tomohiro Takano, Taishi Onodera, Yu Adachi, Saya Moriyama, Kazutaka Terahara, Natsuo Tachikawa, Yoshihiro Yoshimura, Hiroaki Sasaki, Hiroshi Horiuchi, Nobuyuki Miyata, Kazuhito Miyazaki, Michiko Koga, Kazuhiko Ikeuchi, Hiroyuki Nagai, Makoto Saito, Eisuke Adachi, Hiroshi Yotsuyanagi, Satoshi Kutsuna, Akira Kawashima, Yusuke Miyazato, Noriko Kinoshita, Chiyoko Kouno, Kensuke Tanaka, Yoshimasa Takahashi, Tadaki Suzuki, Tetsuro Matano, Jun Ohashi, Ai Kawana-Tachikawa

Summary: The study found a significant association between the HLA-DRB1*09:01 allele and severe COVID-19, with a higher risk compared to preexisting medical conditions such as hypertension, diabetes, and cardiovascular diseases. These results suggest a potential role for HLA in predisposing individuals to severe COVID-19.
Article Immunology

A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site

Taishi Onodera, Shunsuke Kita, Yu Adachi, Saya Moriyama, Akihiko Sato, Takao Nomura, Shuhei Sakakibara, Takeshi Inoue, Takashi Tadokoro, Yuki Anraku, Kohei Yumoto, Cong Tian, Hideo Fukuhara, Michihito Sasaki, Yasuko Orba, Nozomi Shiwa, Naoko Iwata, Noriyo Nagata, Tateki Suzuki, Jiei Sasaki, Tsuyoshi Sekizuka, Keisuke Tonouchi, Lin Sun, Shuetsu Fukushi, Hiroyuki Satofuka, Yasuhiro Kazuki, Mitsuo Oshimura, Tomohiro Kurosaki, Makoto Kuroda, Yoshiharu Matsuura, Tadaki Suzuki, Hirofumi Sawa, Takao Hashiguchi, Katsumi Maenaka, Yoshimasa Takahashi

Summary: A potent neutralizing antibody targeting the spike protein receptor-binding site was identified, which can effectively neutralize various SARS-related coronaviruses and their variants, through coordinated recognition of non-RBS conserved sites and RBS. The antibody's ability to reduce virus titers and morbidity through low-dose therapeutic treatment in hamsters suggests potential for therapeutic and vaccine design to combat broad spectrum of coronaviruses.

IMMUNITY (2021)

Article Immunology

Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants

Saya Moriyama, Yu Adachi, Takashi Sato, Keisuke Tonouchi, Lin Sun, Shuetsu Fukushi, Souichi Yamada, Hitomi Kinoshita, Kiyoko Nojima, Takayuki Kanno, Minoru Tobiume, Keita Ishijima, Yudai Kuroda, Eun-Sil Park, Taishi Onodera, Takayuki Matsumura, Tomohiro Takano, Kazutaka Terahara, Masanori Isogawa, Ayae Nishiyama, Ai Kawana-Tachikawa, Masaharu Shinkai, Natsuo Tachikawa, Shigeki Nakamura, Takahiro Okai, Kazu Okuma, Tetsuro Matano, Tsuguto Fujimoto, Ken Maeda, Makoto Ohnishi, Takaji Wakita, Tadaki Suzuki, Yoshimasa Takahashi

Summary: Antibody titers against SARS-CoV-2 decrease over time, but the neutralizing potency against the original virus and variants actually improves with time. Late convalescent antibodies show increased neutralization potency against variants, suggesting that antibody response maturation enhances cross-neutralizing ability against circulating variants. This indicates that declining antibody titers may not necessarily mean declining protection.

IMMUNITY (2021)

Article Multidisciplinary Sciences

On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19

Shoji Miki, Hiroaki Sasaki, Hiroshi Horiuchi, Nobuyuki Miyata, Yukihiro Yoshimura, Kazuhito Miyazaki, Takayuki Matsumura, Yoshimasa Takahashi, Tadaki Suzuki, Tetsuro Matano, Ai Kawana-Tachikawa, Natsuo Tachikawa

Summary: This study demonstrates that SARS-CoV-2 RNAemia is a potent predictive marker of COVID-19 critical condition and mortality, with an adjusted OR for critical condition as high as 125.71.

PLOS ONE (2021)

Article Immunology

Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses

Ryo Shinnakasu, Shuhei Sakakibara, Hiromi Yamamoto, Po-Hung Wang, Saya Moriyama, Nicolas Sax, Chikako Ono, Atsushi Yamanaka, Yu Adachi, Taishi Onodera, Takashi Sato, Masaharu Shinkai, Ryosuke Suzuki, Yoshiharu Matsuura, Noritaka Hashii, Yoshimasa Takahashi, Takeshi Inoue, Kazuo Yamashita, Tomohiro Kurosaki

Summary: Introducing N-linked glycans onto the RBD of SARS-CoV-2 can enhance humoral responses to the more conserved core-RBD, resulting in higher proportions of core-RBD-specific GC B cells and antibody responses with significant neutralizing activity against SARS-CoV, SARS-CoV-2, and bat WIV1-CoV, which has implications for designing vaccines against SARS-like viruses.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection

Mizuki Fujisawa, Yu Adachi, Taishi Onodera, Nozomi Shiwa-Sudo, Naoko Iwata-Yoshikawa, Noriyo Nagata, Tadaki Suzuki, Shinji Takeoka, Yoshimasa Takahashi

Summary: The SARS-CoV-2 nucleocapsid protein is the main target for COVID-19 diagnostic PCR and antigen rapid diagnostic tests. Antibody-antigen binding is crucial for the effectiveness of antigen rapid diagnostic tests. Two high-affinity antibodies against the nucleocapsid protein were successfully isolated, one specifically binds to SARS-CoV-2 NP and the other shows cross-reactivity to SARS-CoV NP. These antibodies exhibit enhanced sensitivity for nucleocapsid protein detection and can be used for more sensitive and specific antigen rapid diagnostic tests.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2023)

Review Immunology

Humoral immunity for durable control of SARS-CoV-2 and its variants

Ryutaro Kotaki, Saya Moriyama, Yoshimasa Takahashi

Summary: The ongoing COVID-19 pandemic is due to the emergence of SARS-CoV-2 variants, emphasizing the need for vaccines targeting these variants. This review focuses on the humoral immune responses to SARS-CoV-2 variants, particularly the breadth of antibody activity. Research shows that the maturation of humoral immunity over time enhances antibody potency and breadth against variants following infection or vaccination. Memory B cells play a key role in this process, as the reactivity of their B-cell antigen receptors determines the recalled antibody potency and breadth after exposure. The evolution of memory B cells significantly improves their reactivity to antigenically distinct Omicron variants, providing an immunological basis for durable and broad control of SARS-CoV-2 variants.

INFLAMMATION AND REGENERATION (2023)

Article Biochemistry & Molecular Biology

Majority of alpha2,6-sialylated glycans in the adult mouse brain exist in O-glycans: SALSA-MS analysis for knockout mice of alpha2,6-sialyltransferase genes

Yuhsuke Ohmi, Takashi Nishikaze, Yoko Kitaura, Takako Ito, Satoko Yamamoto, Fumihiro Sugiyama, Makoto Matsuyama, Yoshimasa Takahashi, Akira Takeda, Toshio Kawahara, Tetsuya Okajima, Keiko Furukawa, Koichi Furukawa

Summary: This study investigated the expression and function of St6gal genes and their products in the adult mouse brain. It was found that alpha 2,6-sialylated N-glycans were scarcely detected in adult mouse brain tissues, with the majority of these glycans being O-linked. Further mass spectrometry analysis revealed that the majority of alpha 2,6-sialylated O-glycans were disialyl-T antigen and sialyl-(6)T antigen.

GLYCOBIOLOGY (2021)

Article Immunology

Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in Japan

Tomohiro Takano, Takayuki Matsumura, Yu Adachi, Kazutaka Terahara, Saya Moriyama, Taishi Onodera, Ayae Nishiyama, Ai Kawana-Tachikawa, Shoji Miki, Kaori Hosoya-Nakayama, Midori Nakamura-Hoshi, Sayuri Seki, Natsuo Tachikawa, Yukihiro Yoshimura, Nobuyuki Miyata, Hiroshi Horiuchi, Hiroaki Sasaki, Kazuhito Miyazaki, Noriko Kinoshita, Tsutomu Sudo, Yutaro Akiyama, Rubuna Sato, Tadaki Suzuki, Tetsuro Matano, Yoshimasa Takahashi

Summary: An expanded myeloid cell compartment is a key feature of severe COVID-19, with polymorphonuclear (PMN)-MDSCs selectively expanding in survivors of severe cases in Japan, positively correlating with IL-8 levels. This transient expansion of PMN-MDSC subset could serve as a predictor of prognosis in severe COVID-19 cases.

INTERNATIONAL IMMUNOLOGY (2021)

暂无数据